Biopsy-proven renal involvement and prognosis in 13 hispanic patients with primary Sjogren syndrome

被引:4
作者
Luis Carrillo-Perez, Diego [1 ]
Tejeda-Maldonado, Javier [1 ]
Garza-Garcia, Carlos [2 ]
Soto-Abraham, Virgilia [3 ]
Hernandez-Molina, Gabriela [4 ]
Arnoldo Molina-Paredes, Giovanni [5 ]
Uribe-Uribe, Norma O. [5 ]
Morales-Buenrostro, Luis E. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nefrol & Metab Mineral, Ciudad De Mexico, Mexico
[2] Inst Nacl Cardiol Ignacio Chavez, Dept Nefrol, Ciudad De Mexico, Mexico
[3] Inst Nacl Cardiol Ignacio Chavez, Dept Patol, Ciudad De Mexico, Mexico
[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Inmunol & Reumatol, Ciudad De Mexico, Mexico
[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Ciudad De Mexico, Mexico
来源
MEDICINA CLINICA | 2018年 / 150卷 / 02期
关键词
Sjogren syndrome; Glomerulonephritis; Interstitial nephritis; Biopsy; Hispanic; ANTIBODIES; DISEASE;
D O I
10.1016/j.medcli.2017.06.050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aim of this study was to describe a case series of 13 Hispanic patients with primary Sjogren syndrome (pSS) and biopsy-proven renal involvement. Methods: We describe the clinical, serological and histological characteristics as well as the prognosis in a group of patients with pSS and biopsy-proven renal involvement, treated in 2 referral nephrology units in Mexico City. Results: Thirteen patients with pSS underwent kidney biopsy (KB) over a period of 27 years. The median duration from pSS diagnosis to KB was 13.9 months. Seven patients (54%) had glomerulonephritis and 6 patients (46%) had tubulointerstitial nephritis. All patients were treated with corticosteroids and/or immunosuppressants. Eight patients (62%) remained stable or their renal function improved after a median follow-up of 12 months. Conclusions: This case series reflects the broad spectrum of renal involvement in pSS. We observed that in our Hispanic population, glomerular involvement was the most frequent abnormality, mainly membranous glomerulopathy, followed by tubulointerstitial disease. Tubular atrophy and interstitial fibrosis were also common biopsy findings. Treatment with corticosteroids or other immunosuppressive agents appear to slow renal disease progression. (C) 2017 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 19 条
  • [1] Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients
    Baldini, Chiara
    Pepe, Pasquale
    Quartuccio, Luca
    Priori, Roberta
    Bartoloni, Elena
    Alunno, Alessia
    Gattamelata, Angelica
    Maset, Marta
    Modesti, Mariagrazia
    Tavoni, Antonio
    De Vita, Salvatore
    Gerli, Roberto
    Valesini, Guido
    Bombardieri, Stefano
    [J]. RHEUMATOLOGY, 2014, 53 (05) : 839 - 844
  • [2] Clinical and morphological features of kidney involvement in primary Sjogren's syndrome
    Bossini, N
    Savoldi, S
    Franceschini, F
    Mombelloni, S
    Baronio, M
    Cavazzana, I
    Viola, BF
    Valzorio, B
    Mazzucchelli, C
    Cattaneo, R
    Scolari, F
    Maiorca, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (12) : 2328 - 2336
  • [3] Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity
    Candon, S.
    Gottenberg, J. E.
    Bengoufa, D.
    Chatenoud, L.
    Mariette, X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) : 1208 - 1212
  • [4] Tubulointerstitial nephritis in primary Sjogren syndrome: clinical manifestations and response to treatment
    Evans, Rhys D. R.
    Laing, Christopher M.
    Ciurtin, Coziana
    Walsh, Stephen B.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [5] Renal involvement in primary Sjogren syndrome
    Francois, Helene
    Mariette, Xavier
    [J]. NATURE REVIEWS NEPHROLOGY, 2016, 12 (02) : 82 - 93
  • [6] Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome
    Goules, A
    Masouridi, S
    Tziofas, AG
    Ioannidis, JPA
    Skopouli, FN
    Moutsopoulos, HM
    [J]. MEDICINE, 2000, 79 (04) : 241 - 249
  • [7] Clinically Significant Renal Involvement in Primary Sjogren's Syndrome
    Goules, Andreas V.
    Tatouli, Ioanna P.
    Moutsopoulos, Haralampos M.
    Tzioufas, Athanasios G.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (11): : 2945 - 2953
  • [8] The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome
    Hernandez-Molina, Gabriela
    Leal-Alegre, Gustavo
    Michel-Peregrina, Martha
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (03) : 123 - 125
  • [9] A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjogren's syndrome
    Jasiek, Magali
    Karras, Alexandre
    Le Guern, Veronique
    Krastinova, Evguenia
    Mesbah, Rafik
    Faguer, Stanislas
    Jourde-Chiche, Noemie
    Fauchais, Anne-Laure
    Chiche, Laurent
    Dernis, Emmanuelle
    Moulis, Guillaume
    Fraison, Jean-Baptiste
    Lazaro, Estibaliz
    Jullien, Perrine
    Hachulla, Eric
    Le Quellec, Alain
    Remy, Philippe
    Hummel, Aurelie
    Costedoat-Chalumeau, Nathalie
    Ronco, Pierre
    Vanhille, Philippe
    Meas-Yedid, Vannary
    Cordonnier, Carole
    Ferlicot, Sophie
    Daniel, Laurent
    Seror, Raphaele
    Mariette, Xavier
    Thervet, Eric
    Francois, Helene
    Terrier, Benjamin
    [J]. RHEUMATOLOGY, 2017, 56 (03) : 362 - 370
  • [10] Sjogren's syndrome - not just Sicca: renal involvement in Sjogren's syndrome
    Kaufman, I.
    Schwartz, D.
    Caspi, D.
    Paran, D.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (03) : 213 - 218